Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Levosalbutamol (0.31mg) Respule
Therapeutic Category
Asthma, Pulmonary, Respiratory
Dosage Form
Respule
Packaging Type
Pack
Packaging
4x5x2.5ml
Price
₹73.75/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Critsal 0.31 Respule is a specialized respiratory medication containing Levosalbutamol (0.31mg). It is designed to provide effective relief from bronchospasm in patients with asthma and chronic obstructive pulmonary disease (COPD). Levosalbutamol, a short-acting beta-agonist (SABA), works by relaxing the muscles in the airways, thereby improving airflow and easing breathing. This makes it particularly beneficial for managing acute asthma attacks and respiratory conditions associated with airway obstruction.
The respule form allows for administration through nebulization, ensuring direct delivery of the medication to the lungs for rapid and targeted action. It is especially suitable for individuals who have difficulty using inhalers, such as young children or elderly patients. Critsal 0.31 Respule helps alleviate symptoms like wheezing, shortness of breath, and chest tightness, enabling better respiratory function and improving the quality of life.
May cause mild tremors, headache, palpitations, or throat irritation. Serious side effects are rare.
Indicated for the treatment and prevention of bronchospasm in asthma and COPD.
Use under medical supervision. Follow the prescribed dosage and consult your doctor if symptoms persist or worsen.
Store below 25°C in a cool, dry place. Protect from light and keep out of reach of children.
Composition : Ambroxol (7.5mg) + Levosalbutamol (0.25mg) + Guaifenesin (12.5mg)
Composition : Levosalbutamol (0.31mg) Respule
Composition : Levosalbutamol (0.5mg/5ml) + Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml)
Composition : Levosulpiride (75mg) + Rabeprazole (20mg)
Composition : Levosulpiride (12.5mg/ml) Injection
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (0.5mg) + Formoterol (20mcg) Respule
Composition : Budesonide (400mcg) + Formoterol (6mcg) Rota Caps
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Levosalbutamol Respules are used for the treatment of bronchospasm, asthma, COPD, wheezing, and acute respiratory distress. They are widely used in nebulization therapy, making them a strong respiratory and hospital-care segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong demand in hospitals, emergency care, pediatric clinics, and respiratory therapy centers. Respules are commonly used in nebulizer treatments, ensuring consistent institutional and pharmacy demand, especially in asthma and COPD cases.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory and nebulization formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from hospital procurement, emergency usage, chronic respiratory disease demand, and steady repeat prescriptions when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this nebulization formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.